Due to the COVID-19 pandemic, the global Gliquidone (CAS 33342-05-1) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Glequinone Tablets accounting for % of the Gliquidone (CAS 33342-05-1) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

Glycollinone is a second-generation oral sulfonylurea hypoglycemic agent. It is a highly active pro-islet β-cell agent that binds to specific receptors on the islet β-cell membrane and induces the production of appropriate amounts of insulin to lower blood glucose levels.

Global Gliquidone (CAS 33342-05-1) Scope and Segment

Gliquidone (CAS 33342-05-1) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gliquidone (CAS 33342-05-1) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Glequinone Tablets

Glequinone Sustained Release Tablets

Glequinone Capsule

Others

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

BY COMPANY

Vanguard Pharma

Yiling Pharma

CR Double-Crane

TIPR

Jinheng Pharma

Dexa Medica

Boehringer Ingelheim

Menarini Belgium

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

1 Study Coverage

1.1 Gliquidone (CAS 33342-05-1) Product Introduction

1.2 Market by Type

1.2.1 Global Gliquidone (CAS 33342-05-1) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Glequinone Tablets

1.2.3 Glequinone Sustained Release Tablets

1.2.4 Glequinone Capsule

1.2.5 Others

1.3 Market by Application

1.3.1 Global Gliquidone (CAS 33342-05-1) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Gliquidone (CAS 33342-05-1) Sales Estimates and Forecasts 2017-2028

2.2 Global Gliquidone (CAS 33342-05-1) Revenue Estimates and Forecasts 2017-2028

2.3 Global Gliquidone (CAS 33342-05-1) Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Gliquidone (CAS 33342-05-1) Sales by Region

2.4.1 Global Gliquidone (CAS 33342-05-1) Sales by Region (2017-2022)

2.4.2 Global Sales Gliquidone (CAS 33342-05-1) by Region (2023-2028)

2.5 Global Gliquidone (CAS 33342-05-1) Revenue by Region

2.5.1 Global Gliquidone (CAS 33342-05-1) Revenue by Region (2017-2022)

2.5.2 Global Gliquidone (CAS 33342-05-1) Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Gliquidone (CAS 33342-05-1) Sales by Manufacturers

3.1.1 Global Top Gliquidone (CAS 33342-05-1) Manufacturers by Sales (2017-2022)

3.1.2 Global Gliquidone (CAS 33342-05-1) Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gliquidone (CAS 33342-05-1) in 2021

3.2 Global Gliquidone (CAS 33342-05-1) Revenue by Manufacturers

3.2.1 Global Gliquidone (CAS 33342-05-1) Revenue by Manufacturers (2017-2022)

3.2.2 Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Gliquidone (CAS 33342-05-1) Revenue in 2021

3.3 Global Gliquidone (CAS 33342-05-1) Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Gliquidone (CAS 33342-05-1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Gliquidone (CAS 33342-05-1) Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Gliquidone (CAS 33342-05-1) Sales by Type

4.1.1 Global Gliquidone (CAS 33342-05-1) Historical Sales by Type (2017-2022)

4.1.2 Global Gliquidone (CAS 33342-05-1) Forecasted Sales by Type (2023-2028)

4.1.3 Global Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2017-2028)

4.2 Global Gliquidone (CAS 33342-05-1) Revenue by Type

4.2.1 Global Gliquidone (CAS 33342-05-1) Historical Revenue by Type (2017-2022)

4.2.2 Global Gliquidone (CAS 33342-05-1) Forecasted Revenue by Type (2023-2028)

4.2.3 Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Type (2017-2028)

4.3 Global Gliquidone (CAS 33342-05-1) Price by Type

4.3.1 Global Gliquidone (CAS 33342-05-1) Price by Type (2017-2022)

4.3.2 Global Gliquidone (CAS 33342-05-1) Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Gliquidone (CAS 33342-05-1) Sales by Application

5.1.1 Global Gliquidone (CAS 33342-05-1) Historical Sales by Application (2017-2022)

5.1.2 Global Gliquidone (CAS 33342-05-1) Forecasted Sales by Application (2023-2028)

5.1.3 Global Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2017-2028)

5.2 Global Gliquidone (CAS 33342-05-1) Revenue by Application

5.2.1 Global Gliquidone (CAS 33342-05-1) Historical Revenue by Application (2017-2022)

5.2.2 Global Gliquidone (CAS 33342-05-1) Forecasted Revenue by Application (2023-2028)

5.2.3 Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Application (2017-2028)

5.3 Global Gliquidone (CAS 33342-05-1) Price by Application

5.3.1 Global Gliquidone (CAS 33342-05-1) Price by Application (2017-2022)

5.3.2 Global Gliquidone (CAS 33342-05-1) Price Forecast by Application (2023-2028)

6 North America

6.1 North America Gliquidone (CAS 33342-05-1) Market Size by Type

6.1.1 North America Gliquidone (CAS 33342-05-1) Sales by Type (2017-2028)

6.1.2 North America Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2028)

6.2 North America Gliquidone (CAS 33342-05-1) Market Size by Application

6.2.1 North America Gliquidone (CAS 33342-05-1) Sales by Application (2017-2028)

6.2.2 North America Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2028)

6.3 North America Gliquidone (CAS 33342-05-1) Market Size by Country

6.3.1 North America Gliquidone (CAS 33342-05-1) Sales by Country (2017-2028)

6.3.2 North America Gliquidone (CAS 33342-05-1) Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Gliquidone (CAS 33342-05-1) Market Size by Type

7.1.1 Europe Gliquidone (CAS 33342-05-1) Sales by Type (2017-2028)

7.1.2 Europe Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2028)

7.2 Europe Gliquidone (CAS 33342-05-1) Market Size by Application

7.2.1 Europe Gliquidone (CAS 33342-05-1) Sales by Application (2017-2028)

7.2.2 Europe Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2028)

7.3 Europe Gliquidone (CAS 33342-05-1) Market Size by Country

7.3.1 Europe Gliquidone (CAS 33342-05-1) Sales by Country (2017-2028)

7.3.2 Europe Gliquidone (CAS 33342-05-1) Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Gliquidone (CAS 33342-05-1) Market Size by Type

8.1.1 Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Type (2017-2028)

8.1.2 Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2028)

8.2 Asia Pacific Gliquidone (CAS 33342-05-1) Market Size by Application

8.2.1 Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Application (2017-2028)

8.2.2 Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2028)

8.3 Asia Pacific Gliquidone (CAS 33342-05-1) Market Size by Region

8.3.1 Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Region (2017-2028)

8.3.2 Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Gliquidone (CAS 33342-05-1) Market Size by Type

9.1.1 Latin America Gliquidone (CAS 33342-05-1) Sales by Type (2017-2028)

9.1.2 Latin America Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2028)

9.2 Latin America Gliquidone (CAS 33342-05-1) Market Size by Application

9.2.1 Latin America Gliquidone (CAS 33342-05-1) Sales by Application (2017-2028)

9.2.2 Latin America Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2028)

9.3 Latin America Gliquidone (CAS 33342-05-1) Market Size by Country

9.3.1 Latin America Gliquidone (CAS 33342-05-1) Sales by Country (2017-2028)

9.3.2 Latin America Gliquidone (CAS 33342-05-1) Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Gliquidone (CAS 33342-05-1) Market Size by Type

10.1.1 Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Type (2017-2028)

10.1.2 Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2028)

10.2 Middle East and Africa Gliquidone (CAS 33342-05-1) Market Size by Application

10.2.1 Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Application (2017-2028)

10.2.2 Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2028)

10.3 Middle East and Africa Gliquidone (CAS 33342-05-1) Market Size by Country

10.3.1 Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Country (2017-2028)

10.3.2 Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Vanguard Pharma

11.1.1 Vanguard Pharma Corporation Information

11.1.2 Vanguard Pharma Overview

11.1.3 Vanguard Pharma Gliquidone (CAS 33342-05-1) Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Vanguard Pharma Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Vanguard Pharma Recent Developments

11.2 Yiling Pharma

11.2.1 Yiling Pharma Corporation Information

11.2.2 Yiling Pharma Overview

11.2.3 Yiling Pharma Gliquidone (CAS 33342-05-1) Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Yiling Pharma Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Yiling Pharma Recent Developments

11.3 CR Double-Crane

11.3.1 CR Double-Crane Corporation Information

11.3.2 CR Double-Crane Overview

11.3.3 CR Double-Crane Gliquidone (CAS 33342-05-1) Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 CR Double-Crane Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 CR Double-Crane Recent Developments

11.4 TIPR

11.4.1 TIPR Corporation Information

11.4.2 TIPR Overview

11.4.3 TIPR Gliquidone (CAS 33342-05-1) Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 TIPR Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 TIPR Recent Developments

11.5 Jinheng Pharma

11.5.1 Jinheng Pharma Corporation Information

11.5.2 Jinheng Pharma Overview

11.5.3 Jinheng Pharma Gliquidone (CAS 33342-05-1) Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Jinheng Pharma Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Jinheng Pharma Recent Developments

11.6 Dexa Medica

11.6.1 Dexa Medica Corporation Information

11.6.2 Dexa Medica Overview

11.6.3 Dexa Medica Gliquidone (CAS 33342-05-1) Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Dexa Medica Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Dexa Medica Recent Developments

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Corporation Information

11.7.2 Boehringer Ingelheim Overview

11.7.3 Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Boehringer Ingelheim Recent Developments

11.8 Menarini Belgium

11.8.1 Menarini Belgium Corporation Information

11.8.2 Menarini Belgium Overview

11.8.3 Menarini Belgium Gliquidone (CAS 33342-05-1) Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Menarini Belgium Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Menarini Belgium Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Gliquidone (CAS 33342-05-1) Industry Chain Analysis

12.2 Gliquidone (CAS 33342-05-1) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Gliquidone (CAS 33342-05-1) Production Mode & Process

12.4 Gliquidone (CAS 33342-05-1) Sales and Marketing

12.4.1 Gliquidone (CAS 33342-05-1) Sales Channels

12.4.2 Gliquidone (CAS 33342-05-1) Distributors

12.5 Gliquidone (CAS 33342-05-1) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Gliquidone (CAS 33342-05-1) Industry Trends

13.2 Gliquidone (CAS 33342-05-1) Market Drivers

13.3 Gliquidone (CAS 33342-05-1) Market Challenges

13.4 Gliquidone (CAS 33342-05-1) Market Restraints

14 Key Findings in The Global Gliquidone (CAS 33342-05-1) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Gliquidone (CAS 33342-05-1) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Glequinone Tablets

Table 3. Major Manufacturers of Glequinone Sustained Release Tablets

Table 4. Major Manufacturers of Glequinone Capsule

Table 5. Major Manufacturers of Others

Table 6. Global Gliquidone (CAS 33342-05-1) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Gliquidone (CAS 33342-05-1) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Gliquidone (CAS 33342-05-1) Sales by Region (2017-2022) & (Kg)

Table 9. Global Gliquidone (CAS 33342-05-1) Sales Market Share by Region (2017-2022)

Table 10. Global Gliquidone (CAS 33342-05-1) Sales by Region (2023-2028) & (Kg)

Table 11. Global Gliquidone (CAS 33342-05-1) Sales Market Share by Region (2023-2028)

Table 12. Global Gliquidone (CAS 33342-05-1) Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Region (2017-2022)

Table 14. Global Gliquidone (CAS 33342-05-1) Revenue by Region (2023-2028) & (US$ Million)

Table 15. Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Region (2023-2028)

Table 16. Global Gliquidone (CAS 33342-05-1) Sales by Manufacturers (2017-2022) & (Kg)

Table 17. Global Gliquidone (CAS 33342-05-1) Sales Share by Manufacturers (2017-2022)

Table 18. Global Gliquidone (CAS 33342-05-1) Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 19. Global Gliquidone (CAS 33342-05-1) Revenue Share by Manufacturers (2017-2022)

Table 20. Gliquidone (CAS 33342-05-1) Price by Manufacturers (2017-2022) &(USD/Kg)

Table 21. Global Gliquidone (CAS 33342-05-1) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Gliquidone (CAS 33342-05-1) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gliquidone (CAS 33342-05-1) as of 2021)

Table 23. Gliquidone (CAS 33342-05-1) Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Gliquidone (CAS 33342-05-1) Product Offered

Table 25. Date of Manufacturers Enter into Gliquidone (CAS 33342-05-1) Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Gliquidone (CAS 33342-05-1) Sales by Type (2017-2022) & (Kg)

Table 28. Global Gliquidone (CAS 33342-05-1) Sales by Type (2023-2028) & (Kg)

Table 29. Global Gliquidone (CAS 33342-05-1) Sales Share by Type (2017-2022)

Table 30. Global Gliquidone (CAS 33342-05-1) Sales Share by Type (2023-2028)

Table 31. Global Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2022) & (US$ Million)

Table 32. Global Gliquidone (CAS 33342-05-1) Revenue by Type (2023-2028) & (US$ Million)

Table 33. Global Gliquidone (CAS 33342-05-1) Revenue Share by Type (2017-2022)

Table 34. Global Gliquidone (CAS 33342-05-1) Revenue Share by Type (2023-2028)

Table 35. Gliquidone (CAS 33342-05-1) Price by Type (2017-2022) & (USD/Kg)

Table 36. Global Gliquidone (CAS 33342-05-1) Price Forecast by Type (2023-2028) & (USD/Kg)

Table 37. Global Gliquidone (CAS 33342-05-1) Sales by Application (2017-2022) & (Kg)

Table 38. Global Gliquidone (CAS 33342-05-1) Sales by Application (2023-2028) & (Kg)

Table 39. Global Gliquidone (CAS 33342-05-1) Sales Share by Application (2017-2022)

Table 40. Global Gliquidone (CAS 33342-05-1) Sales Share by Application (2023-2028)

Table 41. Global Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2022) & (US$ Million)

Table 42. Global Gliquidone (CAS 33342-05-1) Revenue by Application (2023-2028) & (US$ Million)

Table 43. Global Gliquidone (CAS 33342-05-1) Revenue Share by Application (2017-2022)

Table 44. Global Gliquidone (CAS 33342-05-1) Revenue Share by Application (2023-2028)

Table 45. Gliquidone (CAS 33342-05-1) Price by Application (2017-2022) & (USD/Kg)

Table 46. Global Gliquidone (CAS 33342-05-1) Price Forecast by Application (2023-2028) & (USD/Kg)

Table 47. North America Gliquidone (CAS 33342-05-1) Sales by Type (2017-2022) & (Kg)

Table 48. North America Gliquidone (CAS 33342-05-1) Sales by Type (2023-2028) & (Kg)

Table 49. North America Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2022) & (US$ Million)

Table 50. North America Gliquidone (CAS 33342-05-1) Revenue by Type (2023-2028) & (US$ Million)

Table 51. North America Gliquidone (CAS 33342-05-1) Sales by Application (2017-2022) & (Kg)

Table 52. North America Gliquidone (CAS 33342-05-1) Sales by Application (2023-2028) & (Kg)

Table 53. North America Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2022) & (US$ Million)

Table 54. North America Gliquidone (CAS 33342-05-1) Revenue by Application (2023-2028) & (US$ Million)

Table 55. North America Gliquidone (CAS 33342-05-1) Sales by Country (2017-2022) & (Kg)

Table 56. North America Gliquidone (CAS 33342-05-1) Sales by Country (2023-2028) & (Kg)

Table 57. North America Gliquidone (CAS 33342-05-1) Revenue by Country (2017-2022) & (US$ Million)

Table 58. North America Gliquidone (CAS 33342-05-1) Revenue by Country (2023-2028) & (US$ Million)

Table 59. Europe Gliquidone (CAS 33342-05-1) Sales by Type (2017-2022) & (Kg)

Table 60. Europe Gliquidone (CAS 33342-05-1) Sales by Type (2023-2028) & (Kg)

Table 61. Europe Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2022) & (US$ Million)

Table 62. Europe Gliquidone (CAS 33342-05-1) Revenue by Type (2023-2028) & (US$ Million)

Table 63. Europe Gliquidone (CAS 33342-05-1) Sales by Application (2017-2022) & (Kg)

Table 64. Europe Gliquidone (CAS 33342-05-1) Sales by Application (2023-2028) & (Kg)

Table 65. Europe Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2022) & (US$ Million)

Table 66. Europe Gliquidone (CAS 33342-05-1) Revenue by Application (2023-2028) & (US$ Million)

Table 67. Europe Gliquidone (CAS 33342-05-1) Sales by Country (2017-2022) & (Kg)

Table 68. Europe Gliquidone (CAS 33342-05-1) Sales by Country (2023-2028) & (Kg)

Table 69. Europe Gliquidone (CAS 33342-05-1) Revenue by Country (2017-2022) & (US$ Million)

Table 70. Europe Gliquidone (CAS 33342-05-1) Revenue by Country (2023-2028) & (US$ Million)

Table 71. Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Type (2017-2022) & (Kg)

Table 72. Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Type (2023-2028) & (Kg)

Table 73. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2022) & (US$ Million)

Table 74. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Type (2023-2028) & (US$ Million)

Table 75. Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Application (2017-2022) & (Kg)

Table 76. Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Application (2023-2028) & (Kg)

Table 77. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2022) & (US$ Million)

Table 78. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Application (2023-2028) & (US$ Million)

Table 79. Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Region (2017-2022) & (Kg)

Table 80. Asia Pacific Gliquidone (CAS 33342-05-1) Sales by Region (2023-2028) & (Kg)

Table 81. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Region (2017-2022) & (US$ Million)

Table 82. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue by Region (2023-2028) & (US$ Million)

Table 83. Latin America Gliquidone (CAS 33342-05-1) Sales by Type (2017-2022) & (Kg)

Table 84. Latin America Gliquidone (CAS 33342-05-1) Sales by Type (2023-2028) & (Kg)

Table 85. Latin America Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2022) & (US$ Million)

Table 86. Latin America Gliquidone (CAS 33342-05-1) Revenue by Type (2023-2028) & (US$ Million)

Table 87. Latin America Gliquidone (CAS 33342-05-1) Sales by Application (2017-2022) & (Kg)

Table 88. Latin America Gliquidone (CAS 33342-05-1) Sales by Application (2023-2028) & (Kg)

Table 89. Latin America Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2022) & (US$ Million)

Table 90. Latin America Gliquidone (CAS 33342-05-1) Revenue by Application (2023-2028) & (US$ Million)

Table 91. Latin America Gliquidone (CAS 33342-05-1) Sales by Country (2017-2022) & (Kg)

Table 92. Latin America Gliquidone (CAS 33342-05-1) Sales by Country (2023-2028) & (Kg)

Table 93. Latin America Gliquidone (CAS 33342-05-1) Revenue by Country (2017-2022) & (US$ Million)

Table 94. Latin America Gliquidone (CAS 33342-05-1) Revenue by Country (2023-2028) & (US$ Million)

Table 95. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Type (2017-2022) & (Kg)

Table 96. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Type (2023-2028) & (Kg)

Table 97. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Type (2017-2022) & (US$ Million)

Table 98. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Type (2023-2028) & (US$ Million)

Table 99. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Application (2017-2022) & (Kg)

Table 100. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Application (2023-2028) & (Kg)

Table 101. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Application (2017-2022) & (US$ Million)

Table 102. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Application (2023-2028) & (US$ Million)

Table 103. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Country (2017-2022) & (Kg)

Table 104. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales by Country (2023-2028) & (Kg)

Table 105. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Country (2017-2022) & (US$ Million)

Table 106. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue by Country (2023-2028) & (US$ Million)

Table 107. Vanguard Pharma Corporation Information

Table 108. Vanguard Pharma Description and Major Businesses

Table 109. Vanguard Pharma Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 110. Vanguard Pharma Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Vanguard Pharma Recent Developments

Table 112. Yiling Pharma Corporation Information

Table 113. Yiling Pharma Description and Major Businesses

Table 114. Yiling Pharma Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 115. Yiling Pharma Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Yiling Pharma Recent Developments

Table 117. CR Double-Crane Corporation Information

Table 118. CR Double-Crane Description and Major Businesses

Table 119. CR Double-Crane Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 120. CR Double-Crane Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. CR Double-Crane Recent Developments

Table 122. TIPR Corporation Information

Table 123. TIPR Description and Major Businesses

Table 124. TIPR Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 125. TIPR Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. TIPR Recent Developments

Table 127. Jinheng Pharma Corporation Information

Table 128. Jinheng Pharma Description and Major Businesses

Table 129. Jinheng Pharma Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 130. Jinheng Pharma Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Jinheng Pharma Recent Developments

Table 132. Dexa Medica Corporation Information

Table 133. Dexa Medica Description and Major Businesses

Table 134. Dexa Medica Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 135. Dexa Medica Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Dexa Medica Recent Developments

Table 137. Boehringer Ingelheim Corporation Information

Table 138. Boehringer Ingelheim Description and Major Businesses

Table 139. Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 140. Boehringer Ingelheim Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Boehringer Ingelheim Recent Developments

Table 142. Menarini Belgium Corporation Information

Table 143. Menarini Belgium Description and Major Businesses

Table 144. Menarini Belgium Gliquidone (CAS 33342-05-1) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 145. Menarini Belgium Gliquidone (CAS 33342-05-1) Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Menarini Belgium Recent Developments

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Gliquidone (CAS 33342-05-1) Distributors List

Table 150. Gliquidone (CAS 33342-05-1) Customers List

Table 151. Gliquidone (CAS 33342-05-1) Market Trends

Table 152. Gliquidone (CAS 33342-05-1) Market Drivers

Table 153. Gliquidone (CAS 33342-05-1) Market Challenges

Table 154. Gliquidone (CAS 33342-05-1) Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. Gliquidone (CAS 33342-05-1) Product Picture

Figure 3. Global Gliquidone (CAS 33342-05-1) Market Share by Type in 2021 & 2028

Figure 3. Glequinone Tablets Product Picture

Figure 4. Glequinone Sustained Release Tablets Product Picture

Figure 5. Glequinone Capsule Product Picture

Figure 6. Others Product Picture

Figure 7. Global Gliquidone (CAS 33342-05-1) Market Share by Application in 2021 & 2028

Figure 8. Hospital Pharmacies

Figure 9. Retail Pharmacies

Figure 10. Online Pharmacies

Figure 11. Gliquidone (CAS 33342-05-1) Report Years Considered

Figure 12. Global Gliquidone (CAS 33342-05-1) Sales 2017-2028 (Kg)

Figure 13. Global Gliquidone (CAS 33342-05-1) Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global Gliquidone (CAS 33342-05-1) Revenue 2017-2028 (US$ Million)

Figure 15. Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 16. Global Gliquidone (CAS 33342-05-1) Sales Market Share by Region (2017-2022)

Figure 17. Global Gliquidone (CAS 33342-05-1) Sales Market Share by Region (2023-2028)

Figure 18. North America Gliquidone (CAS 33342-05-1) Sales YoY (2017-2028) & (Kg)

Figure 19. North America Gliquidone (CAS 33342-05-1) Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Europe Gliquidone (CAS 33342-05-1) Sales YoY (2017-2028) & (Kg)

Figure 21. Europe Gliquidone (CAS 33342-05-1) Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Asia-Pacific Gliquidone (CAS 33342-05-1) Sales YoY (2017-2028) & (Kg)

Figure 23. Asia-Pacific Gliquidone (CAS 33342-05-1) Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Latin America Gliquidone (CAS 33342-05-1) Sales YoY (2017-2028) & (Kg)

Figure 25. Latin America Gliquidone (CAS 33342-05-1) Revenue YoY (2017-2028) & (US$ Million)

Figure 26. Middle East & Africa Gliquidone (CAS 33342-05-1) Sales YoY (2017-2028) & (Kg)

Figure 27. Middle East & Africa Gliquidone (CAS 33342-05-1) Revenue YoY (2017-2028) & (US$ Million)

Figure 28. The Gliquidone (CAS 33342-05-1) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 29. The Top 5 and 10 Largest Manufacturers of Gliquidone (CAS 33342-05-1) in the World: Market Share by Gliquidone (CAS 33342-05-1) Revenue in 2021

Figure 30. Global Gliquidone (CAS 33342-05-1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 31. Global Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2017-2028)

Figure 32. Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Type (2017-2028)

Figure 33. Global Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2017-2028)

Figure 34. Global Gliquidone (CAS 33342-05-1) Revenue Market Share by Application (2017-2028)

Figure 35. North America Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2017-2028)

Figure 36. North America Gliquidone (CAS 33342-05-1) Revenue Market Share by Type (2017-2028)

Figure 37. North America Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2017-2028)

Figure 38. North America Gliquidone (CAS 33342-05-1) Revenue Market Share by Application (2017-2028)

Figure 39. North America Gliquidone (CAS 33342-05-1) Sales Share by Country (2017-2028)

Figure 40. North America Gliquidone (CAS 33342-05-1) Revenue Share by Country (2017-2028)

Figure 41. U.S. Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 42. Canada Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 43. Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2017-2028)

Figure 44. Europe Gliquidone (CAS 33342-05-1) Revenue Market Share by Type (2017-2028)

Figure 45. Europe Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2017-2028)

Figure 46. Europe Gliquidone (CAS 33342-05-1) Revenue Market Share by Application (2017-2028)

Figure 47. Europe Gliquidone (CAS 33342-05-1) Sales Share by Country (2017-2028)

Figure 48. Europe Gliquidone (CAS 33342-05-1) Revenue Share by Country (2017-2028)

Figure 49. Germany Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 50. France Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 51. U.K. Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 52. Italy Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 53. Russia Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 54. Asia Pacific Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2017-2028)

Figure 55. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue Market Share by Type (2017-2028)

Figure 56. Asia Pacific Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2017-2028)

Figure 57. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue Market Share by Application (2017-2028)

Figure 58. Asia Pacific Gliquidone (CAS 33342-05-1) Sales Share by Region (2017-2028)

Figure 59. Asia Pacific Gliquidone (CAS 33342-05-1) Revenue Share by Region (2017-2028)

Figure 60. China Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 61. Japan Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 62. South Korea Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 63. India Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 64. Australia Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 65. Taiwan Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 66. Indonesia Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 67. Thailand Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 68. Malaysia Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 69. Philippines Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 70. Latin America Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2017-2028)

Figure 71. Latin America Gliquidone (CAS 33342-05-1) Revenue Market Share by Type (2017-2028)

Figure 72. Latin America Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2017-2028)

Figure 73. Latin America Gliquidone (CAS 33342-05-1) Revenue Market Share by Application (2017-2028)

Figure 74. Latin America Gliquidone (CAS 33342-05-1) Sales Share by Country (2017-2028)

Figure 75. Latin America Gliquidone (CAS 33342-05-1) Revenue Share by Country (2017-2028)

Figure 76. Mexico Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 77. Brazil Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 78. Argentina Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 79. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue Market Share by Type (2017-2028)

Figure 81. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Gliquidone (CAS 33342-05-1) Sales Share by Country (2017-2028)

Figure 84. Middle East and Africa Gliquidone (CAS 33342-05-1) Revenue Share by Country (2017-2028)

Figure 85. Turkey Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 86. Saudi Arabia Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 87. U.A.E Gliquidone (CAS 33342-05-1) Revenue (2017-2028) & (US$ Million)

Figure 88. Gliquidone (CAS 33342-05-1) Value Chain

Figure 89. Gliquidone (CAS 33342-05-1) Production Process

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gliquidone (CAS 33342-05-1) Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-4U7640

Global Gliquidone (CAS 33342-05-1) Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions